Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics
US2013079310A1
Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
US2013040913A1
Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US2013040927A1
Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US2012302639A1
Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden death
US2013034535A1
Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
US2005287613A1
Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
US2009093000A1
Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease
US2007003974A1
Cene-E biopolymer marker indicative of age matched control
